Apoptosis Antibodies
Apoptosis refers to the set of ordered biochemical and physical changes in a cell during a specific form of cell death. These changes begin with the rounding and shrinking of the affected cells causing them to lose contact with their neighbors. Later, their endoplasmic reticulum swells and the cisternae begin to form vesicles and vacuoles. In the nucleus, the chromatin condenses and is digested by endogenous nucleases. The nucleus ultimately disintegrates into fragments which are encapsulated into apoptotic bodies. By this point, the plasma membrane has become convoluted and begins blebbing off, forming the surface of the apoptotic bodies, which are then recognized and engulfed by phagocytic cells. In contrast, during necrosis the cell swells and disintegrates in a disordered manner, leading to the destruction of cellular organelles and the rupture of the plasma membrane.
ProSci has a wide variety of apoptosis antibodies. These include antibodies against p53 upregulated modulator of apoptosis (PUMA), Bim, members of the caspase family, death receptors, p53 and many other apoptosis proteins. Additionally, ProSci offers a BAFF and Receptor Detection Set and a TRAIL and Receptor Detection set. ProSci antibodies are appropriate for ELISA, western blot, and immunohistochemistry (IHC) applications as noted for each apoptosis antibody.
Also, we have a TRAIL and TRAIL receptor flyer in the posters section of our resources area of the ProSci website and our TRAIL and TRAIL receptor products were featured in our May 2006 newsletter which is also in the posters section of our resources area.
Apoptosis Antibodies from ProSci:
| Product Name | Catalog # | App. | Reactivity | Description |
|---|---|---|---|---|
| F box and leucine-rich-repeat gene 4 Antibody | 79-639 | WB | Fruit fly | F box and leucine-rich-repeat gene 4 |
| F1A alpha Antibody | 2279 | E, WB, IHC, IF | H, M, R | (CT) A novel death receptor-binding protein |
| F2 Antibody | 25-721 | E, WB | H, M, R | F2 (coagulation factor II (thrombin)) |
| FADD Antibody | 31-008 | E, WB, IHC | H | FADD (Fas (TNFRSF6)-associated via death domain) |
| FAF1 Antibody | 3993 | E, WB, IHC, IF | H, M, R | (CT) Fas-associated protein 1 |
| FAIM Antibody | 2309 | E, WB | H, M | (CT) an apoptosis inhibitor |
| FAS Antibody | 42-121 | E, WB | H | (IN) FAS / CD95 |
| FAS Antibody | XW-7192 | WB | H | Tumor necrosis factor receptor superfamily, member |
| Fas Antibody | 79-640 | WB | H | Fas |
| Fas Ligand Antibody | XP-5130Bt | E, WB | H | Biotin - Anti-Human FasL/Apo1 |
| Fas Ligand Antibody | XP-5130 | E, WB | H | Anti-Human Fas Ligand |
| FAS Monoclonal Antibody | 51-132 | IHC, FACS | n/a | Tumor Necrosis Factor Receptor Superfamily, Member |
| FasL (MAb A11) Antibody | XA-1000 | IHC, FC | M | monoclonal to FasL (mouse) (A11) |
| FasL (MAb H11) (Biotin) Antibody | XA-1001Bt | WB, IHC, FC | M | Biotin - monoclonal to FasL (mouse) (H11) |
| FasL (MAb H11) (FITC) Antibody | XA-1001F | IHC, FC | M | Fluorescein - monoclonal to FasL (mouse) (H11) |
| FasL (MAb H11) Antibody | XA-1001 | WB, IHC, FC | M | monoclonal to FasL (mouse) (H11) |
| FasL (MAb Mike-2) Antibody | XA-1003 | WB, FC | H | monoclonal to FasL (Mike-2) |
| FASLG Antibody | 31-023 | E, WB | H | FASLG (Fas ligand (TNF superfamily, member 6)) |
| FBXL2 Antibody | 25-820 | E, WB | H, M, R | FBXL2 (F-box and leucine-rich repeat protein 2) |
| FBXL5 Antibody | 29-836 | E, WB, IHC | H | FBXL5 (F-box and leucine-rich repeat protein 5) |
| FBXL7 Antibody | 29-839 | E, WB, IHC | H, M, R | FBXL7 (F-box and leucine-rich repeat protein 7) |
| FBXO21 Antibody | 25-830 | E, WB | H, M, R | FBXO21 (F-box protein 21) |
| FBXO24 Antibody | 25-856 | E, WB | H | FBXO24 (F-box protein 24) |
| FBXO24 Antibody | 25-822 | E, WB | H | FBXO24 (F-box protein 24) |
| FBXO25 Antibody | 25-823 | E, WB | H | FBXO25 (F-box protein 25) |
| FBXO25 Antibody | 29-837 | E, WB, IHC | H, D, ZF | FBXO25 (F-box protein 25) |
| FBXO3 Antibody | 29-838 | E, WB, IHC | H, M, R, D | FBXO3 (F-box protein 3) |
| FBXO4 Antibody | 25-824 | E, WB | H | FBXO4 (F-box protein 4) |
| FBXO7 Antibody | 25-825 | E, WB | H | FBXO7 (F-box protein 7) |
| FBXW2 Antibody | 25-821 | E, WB | H, M, R | FBXW2 (F-box and WD repeat domain containing 2) |
| FEM1B Antibody | 30-917 | E, WB | H | FEM1B (fem-1 homolog b (C. elegans)) |
| FKBP6 Antibody | 29-825 | E, WB, IHC | H, M, R, D | FKBP6 (FK506 binding protein 6, 36kDa) |
| FKBP8 Antibody | 46-841 | E | H | FKBP8 / FKBP38 |
| FKHR Antibody | 79-167 | WB, IHC, IF | H, M | FKHR (Phospho-Ser319) |
| FKHR Antibody | 79-154 | WB, IHC, IF | H, M, R | FKHR (Phospho-Ser256) |
| FKHRL1 Antibody | 79-566 | WB | H, M, R | FKHRL1 (Ab-253) |
| FLASH Antibody | 2271 | E, WB, ICC, IF | H | (CT) Homolog of CED4 |
| FLIP Antibody | 1159 | E, WB, IHC, IF, FACS | H, M, R | (NT) FLICE inhibitory protein |
| FLIP Antibody | 2055 | E, WB, ICC, IF | H | (CT) FLICE inhibitory protein |
| FLIP Antibody | 1156 | E, WB, ICC | M | (CT) FLICE inhibitory protein |
| FLIP Antibody | 1161 | E, WB, ICC, IF | H, M, R | (CT) FLICE inhibitory protein |
| Fn14 Antibody | 3951 | E, WB, IHC, IF | H | TWEAK, FGF inducible 14, TRAF |
| FOS Antibody | XW-7105 | WB | H, M, R, B | C-fos |
| FOXO1 Antibody | 27-758 | E, WB | H, M, R | FOXO1 (forkhead box O1) |
| FOXO1 Antibody | 31-152 | E, WB | H, D | FOXO1 (forkhead box O1) |
| FOXO1 Antibody | 27-501 | E, WB | H, M, R | FOXO1 (forkhead box O1) |
| FOXO1A Antibody | 28-788 | E, WB | H | FOXO1A (forkhead box O1A) |
| FOXO3 Antibody | 28-775 | E, WB | H, M, R | FOXO3 (forkhead box O3) |
| FOXO3A Antibody | 28-776 | E, WB | H, M, R, D | FOXO3A (forkhead box O3A) |

